PremiumMarket News3 Penny Stocks to Watch Now, 1/16/25 Eterna announces preclinical study results on ERNA-101 Eterna Therapeutics Faces Nasdaq Compliance and Board Changes PremiumThe FlyEterna completes strategic financial restructuring Eterna, Factor announce license, collaboration agreement Eterna Therapeutics Strikes Key Deal for Disease-Fighting Tech PremiumCompany AnnouncementsEterna Therapeutics Welcomes New Board Member Peter Cicala Eterna files to sell 18.23M shares of common stock for holders EternaAppoints Sanjeev Luther as President and CEO 
